Author: Avalon Health Economics LLC

Reshaping the Clinical Laboratory in the Era of Patient-Centered Outcomes, Accountable Care Organizations, and Pharmacogenomics
December 2, 2013 - 12:59 pm, by
In recent years there has been renewed attention devoted to coordination of medical care services across the continuum of care, particularly in the area of prevention, monitoring, diagnostics, and disease management. This is not entirely new to the U.S. In the early 1990s, as managed care began to widen its reach and increase market share,...
Megan Modic joins Avalon as a Research Assistant
November 25, 2013 - 11:02 am, by
Joining us recently is Megan Modic, who will provide research assistance on a variety of projects. Ms. Modic is currently earning her Bachelor’s degree in Honors Economics and Environmental Science at Drew University, in Madison, NJ, where she is President of The Fund, a student run investment portfolio.
How Big a Problem is Health Care Fraud and Abuse, and How Can We Detect It?
October 22, 2013 - 12:54 pm, by
According to the National Health Care Anti-Fraud Association (NHCAA) and the Blue Cross and Blue Shield Association, the estimated annual costs of health care fraud in the U.S. are more than $70 billion, or about 3% of total national health care expenditures. This is an amount large enough to wipe out the savings from many...
Avalon CEO John Schneider spoke at the 6th Annual Latin American & Canada Clinical Laboratory Symposium, Cartagena, Columbia, October 16-17, organized by Abbott Diagnostics. The title of his talk was “Economics of Cancer Biomarkers: Cost Effectiveness of HE4 in Clinical Decision Making.”
October 21, 2013 - 10:59 am, by
Avalon CEO John Schneider spoke at the 6th Annual Latin American & Canada Clinical Laboratory Symposium, Cartagena, Columbia, October 16th and 17th. The title of his talk was “Economics of Cancer Biomarkers: Cost Effectiveness of HE4 in Clinical Decision Making Dr. Schneider’s presentation focused on a conceptual framework for exploring the economic aspects of cancer...
Avalon Health Economics CEO John Schneider presented at the annual Truck Safety and Litigation Seminar hosted by Marcello & Kivisto LLC law firm
October 12, 2013 - 10:57 am, by
Avalon Health Economics CEO John Schneider presented at the Truck Safety and Litigation Seminar hosted by Marcello & Kivisto LLC law firm in April 2013. In his presentation Dr. Schneider spoke about motor carrier liability cases involving large medical losses, and how Avalon Health Economics uses a common health economics methodology to calculate the “reasonable...
Two new consultants join Avalon Health Economics: Jeff Kamil, MD (U.S. Market Access and Reimbursement) and Stephanie Wels (Research Assistant)
September 16, 2013 - 10:56 am, by
Avalon Health Economics is happy to announce the addition of two new consultants to our panel. Jeff Kamil, MD, joins us in the area of U.S. market access and reimbursement. Jeff worked with John Schneider, Avalon’s CEO, several years ago when John was Director of Research at the California Association of Health Plans. Dr. Kamil...
U.S. Health Care Costs: Disentangling Underlying Trends from the Effects of the Affordable Care Act
August 2, 2013 - 12:40 pm, by
During the health reform discussions leading up to the passage of the Affordable Care Act (“ACA”), there was a lot of talk about the costs of health care services in the U.S. Some argued that the legislation did not go far enough in controlling the underlying upward trends in health care costs, while others argued...
Women and the Affordable Care Act
July 20, 2013 - 12:44 pm, by
Women make about 80% of the health-care decisions for their families, utilize more health care than men, and are the more likely to be the care givers when a family member becomes sick. Females of all ages accounted for 60% of all expenses incurred at doctors’ offices in 2004. According to the Bureau of Labor...
Health Care Costs and Value: An International Perspective
June 20, 2013 - 12:33 pm, by
During the recent debates over the Affordable Care Act (“ACA,” or Obamacare) a commonly raised issue was that U.S. health care does not offer much in the way of “value for money.” The argument, generally, is that we spend a lot more in the U.S. relative to comparable countries but in turn receive poor quality...
Tobacco Butts and Litter Costs
June 18, 2013 - 12:30 pm, by
Tobacco product litter is one of the most ubiquitous forms of litter, accumulating in increasingly large numbers on streets, highways, sidewalks, beaches, storm water drains, waste treatment plants, parks and other public places. Tobacco product litter (“TPL”) is not simply unattractive; it has been shown to be toxic and costly to clean up. More than...